Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Completed 4

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1CNS 1Breast 1

Conditions

Fatigue 2Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neoplasms 1Gastrointestinal Neoplasms 1Chronic Pain 1Breast Neoplasms 1Agnosia 1

Interventions

Cyclophosphamide 909Carboplatin 787pembrolizumab 744Paclitaxel 742Cisplatin 709Bevacizumab 706Gemcitabine 619Docetaxel 579Rituximab 548Radiotherapy 541Dexamethasone 511Nivolumab 488Doxorubicin 444Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 326fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Has results × Acceptance and Commitment Therapy × Clear all
NCT03661840 2025-03-13

Acceptance and Commitment Therapy for Chronic Pain in Cancer Survivors

University of Colorado, Denver

Phase NA Completed
50 enrolled 12 charts

Agnosia, Neoplasms, Chronic Pain

NCT03998618 2024-10-10

Telephone Support for Metastatic Breast Cancer Patients

Indiana University

Phase NA Completed
250 enrolled 20 charts
Breast

Breast Neoplasms, Fatigue

NCT04010227 2022-12-22

Telephone Support for Advanced Gastrointestinal Cancer Patients and Caregivers

Indiana University

Phase NA Completed
84 enrolled 30 charts
Gastrointestinal

Fatigue, Gastrointestinal Neoplasms

NCT02471339 2022-06-14

Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain

National Institutes of Health Clinical Center (CC)

Phase 3 Completed
66 enrolled 17 charts
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡